Evidence map›Paper›PMID 23486265›Full record

ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2013

Noninvasive characterization of the histopathologic features of pulmonary nodules of the lung adenocarcinoma spectrum using computer-aided nodule assessment and risk yield (CANARY)--a pilot study.

Fabien Maldonado, Jennifer M Boland, Sushravya Raghunath, Marie Christine Aubry, Brian J Bartholmai, Mariza Deandrade, Thomas E Hartman, Ronald A Karwoski, Srinivasan Rajagopalan, Anne-Marie Sykes and 4 more

Open access · greenAbstract read
In one paragraph

Article in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 74 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Fabien MaldonadoDepartment of Medicine, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
Jennifer M Boland
Sushravya Raghunath
Marie Christine Aubry
Brian J Bartholmai
Mariza Deandrade
Thomas E Hartman
Ronald A Karwoski
Srinivasan Rajagopalan
Anne-Marie Sykes
Ping Yang
Eunhee S Yi
Richard A Robb
Tobias Peikert
Mayo Clinic · US

Funding

Paul Calabresi Program in Clinical/Translational Research at Mayo ClinicK12CA090628 · NCI · MAYO CLINIC ROCHESTER · PI WEROHA, SARAVUT · 2001 to 2025
$19.7M
Genetic Determinants of Lung Cancer SurvivalR01CA084354 · NCI · MAYO CLINIC ROCHESTER · PI YANG, PING · 2001 to 2012
$4.0M
Anti-Tumor Immunity in Response to a Modified Vaccine Strain Measles VirusK23CA159391 · NCI · MAYO CLINIC ROCHESTER · PI PEIKERT, TOBIAS · 2012 to 2015
$657k
NCI NIH HHS CA90628NCI NIH HHS K12 CA090628NCI NIH HHS K23 CA159391NCI NIH HHS R01 CA084354NCI NIH HHS R01CA84354
6 · The paper itself

Abstract

introductionPulmonary nodules of the adenocarcinoma spectrum are characterized by distinctive morphological and radiologic features and variable prognosis. Noninvasive high-resolution computed tomography-based risk stratification tools are needed to individualize their management.

methodsRadiologic measurements of histopathologic tissue invasion were developed in a training set of 54 pulmonary nodules of the adenocarcinoma spectrum and validated in 86 consecutively resected nodules. Nodules were isolated and characterized by computer-aided analysis, and data were analyzed by Spearman correlation, sensitivity, and specificity and the positive and negative predictive values.

resultsComputer-aided nodule assessment and risk yield (CANARY) can noninvasively characterize pulmonary nodules of the adenocarcinoma spectrum. Unsupervised clustering analysis of high-resolution computed tomography data identified nine unique exemplars representing the basic radiologic building blocks of these lesions. The exemplar distribution within each nodule correlated well with the proportion of histologic tissue invasion, Spearman R = 0.87, p < 0.0001 and 0.89 and p < 0.0001 for the training and the validation set, respectively. Clustering of the exemplars in three-dimensional space corresponding to tissue invasion and lepidic growth was used to develop a CANARY decision algorithm that successfully categorized these pulmonary nodules as "aggressive" (invasive adenocarcinoma) or "indolent" (adenocarcinoma in situ and minimally invasive adenocarcinoma). Sensitivity, specificity, positive predictive value, and negative predictive value of this approach for the detection of aggressive lesions were 95.4, 96.8, 95.4, and 96.8%, respectively, in the training set and 98.7, 63.6, 94.9, and 87.5%, respectively, in the validation set.

conclusionCANARY represents a promising tool to noninvasively risk stratify pulmonary nodules of the adenocarcinoma spectrum.

Indexed as

Diagnosis, Computer-AssistedAdenocarcinomaAdultAgedAged, 80 and overCarcinoma in SituCluster AnalysisFemaleFollow-Up StudiesHumansLungLung NeoplasmsMaleMiddle AgedMultiple Pulmonary NodulesNeoplasm Invasiveness

Identifiers

PMID23486265
PMCPMC3597987
OpenAlexW2027813187

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.